Trial Profile
Efficacy of tacrolimus extended release formulation as an alternative to ciclosporin A in patient with renal impairment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Oct 2014
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin
- Indications Graft-versus-host disease; Renal transplant rejection
- Focus Pharmacokinetics; Therapeutic Use
- 13 Oct 2014 New trial record
- 01 May 2013 Recruitment completed, according to 55th Annual Meeting and Exposition of the American Society of Hematology.